angiotensin receptor blocker (Kyowa Hakko Kirin)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameangiotensin receptor blocker (Kyowa Hakko Kirin)
Drug Alias NameK-868
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor modulatorsPeroxisome proliferator-activated receptor γ agonistsInsulin sensitizers
TargetsAngiotensin II receptorPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Kirin Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A